tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

KTTA Stock Latest News

Pasithea announces activation of trial site at UAB for study of PAS-004
The FlyPasithea announces activation of trial site at UAB for study of PAS-004
6d ago
KTTA
Pasithea Therapeutics Opens New Trial Site for PAS-004
PremiumCompany Announcements
Pasithea Therapeutics Opens New Trial Site for PAS-004
6d ago
8K
KTTA
Pasithea Therapeutics Aligns Executive Compensation Strategy
PremiumCompany Announcements
Pasithea Therapeutics Aligns Executive Compensation Strategy
14d ago
8K
KTTA
Pasithea Therapeutics’ PAS-004 Trial: A Step Forward in NF1 Treatment
PremiumCompany Announcements
Pasithea Therapeutics’ PAS-004 Trial: A Step Forward in NF1 Treatment
14d ago
KTTA
Pasithea Therapeutics’ Promising Phase 1 Study on PAS-004 for Advanced Solid Tumors
PremiumCompany Announcements
Pasithea Therapeutics’ Promising Phase 1 Study on PAS-004 for Advanced Solid Tumors
14d ago
KTTA
Pasithea Therapeutics Expands Clinical Trials to South Korea
PremiumCompany AnnouncementsPasithea Therapeutics Expands Clinical Trials to South Korea
2M ago
8K
KTTA
Pasithea Therapeutics announces activation of two South Korean trial sites
Premium
The Fly
Pasithea Therapeutics announces activation of two South Korean trial sites
2M ago
KTTA
Pasithea announces enrollment of cohort 2 in Phase 1/1b trial of PAS-004
Premium
The Fly
Pasithea announces enrollment of cohort 2 in Phase 1/1b trial of PAS-004
2M ago
KTTA
Pasithea Therapeutics Approves Key Proposals at Annual Meeting
PremiumCompany Announcements
Pasithea Therapeutics Approves Key Proposals at Annual Meeting
2M ago
8K
KTTA
Pasithea completes enrollment, initial dosing from Phase 1/1b trial of PAS-004
PremiumThe Fly
Pasithea completes enrollment, initial dosing from Phase 1/1b trial of PAS-004
3M ago
KTTA
Pasithea Sets Deadline for Shareholder Proposals
PremiumCompany Announcements
Pasithea Sets Deadline for Shareholder Proposals
4M ago
8K
KTTA
Pasithea Therapeutics Faces Nasdaq Delisting Notice
PremiumCompany Announcements
Pasithea Therapeutics Faces Nasdaq Delisting Notice
5M ago
8K
KTTA
Pasithea Therapeutics Expands Stock Offering Limit
PremiumCompany AnnouncementsPasithea Therapeutics Expands Stock Offering Limit
5M ago
8K
KTTA
Pasithea Therapeutics appoints Lee to its SAB
Premium
The Fly
Pasithea Therapeutics appoints Lee to its SAB
5M ago
KTTA
Pasithea Therapeutics presents updated interim data from Phase 1 PAS-004 study
Premium
The Fly
Pasithea Therapeutics presents updated interim data from Phase 1 PAS-004 study
5M ago
KTTA
Pasithea Therapeutics announces preclinical data on PAS-004
PremiumThe Fly
Pasithea Therapeutics announces preclinical data on PAS-004
6M ago
KTTA
Pasithea Therapeutics announces initiation of Phase 1/1b study of PAS-004
PremiumThe Fly
Pasithea Therapeutics announces initiation of Phase 1/1b study of PAS-004
6M ago
KTTA
3 Penny Stocks to Watch Now, 5/8/25
PremiumMarket News
3 Penny Stocks to Watch Now, 5/8/25
6M ago
FOXO
KTTA
Pasithea Therapeutics Raises $6.3 Million in Stock Offering
PremiumCompany Announcements
Pasithea Therapeutics Raises $6.3 Million in Stock Offering
6M ago
8K
KTTA
Pasithea Therapeutics 3.57M share Secondary priced at $1.40
PremiumThe FlyPasithea Therapeutics 3.57M share Secondary priced at $1.40
6M ago
KTTA
Pasithea Therapeutics announces interim data from Phase 1 trial of PAS-004
Premium
The Fly
Pasithea Therapeutics announces interim data from Phase 1 trial of PAS-004
6M ago
KTTA
Pasithea Therapeutics files to sell 3.25M shares of common stock, warrants
Premium
The Fly
Pasithea Therapeutics files to sell 3.25M shares of common stock, warrants
6M ago
KTTA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >